Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

2 common drugs may help treat deadly Middle East Respiratory Syndrome

11.09.2013
The drugs subdue inflammation, reduce viral replication and promote lung repair

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more than 100 people, primarily in the Middle East.

Middle East Respiratory Syndrome, or MERS, was first reported in Saudi Arabia last year. The infection is caused by a coronavirus, called MERS-CoV, which is closely related to several coronaviruses that infect bats. About half of patients who developed the syndrome have died. Currently, there is no proven effective treatment.

The new findings show that a combination of interferon-alpha 2b and ribavirin, drugs routinely used to treat hepatitis C, may be an effective treatment for MERS-CoV infection, said Dr. Angela L. Rasmussen, a research scientist in the Department of Microbiology at the University of Washington in Seattle and co-author of the study.

"Because these two drugs are readily available, they could be used immediately to treat patients infected with MERS-CoV," Rasmussen said.

The study was conducted by researchers from the U.S. National Institute of Allergy and Infectious Diseases; the Universite Pierre et Marie Curie in Paris, France; the University of Manitoba in Winnipeg, Canada; and the University of Washington in Seattle. The results were published online September 8 by the journal Nature Medicine. Darryl Falzarano, of the National Institute of Allergy and Infectious Diseases's Rocky Mountain Laboratory in Hamilton, Mont., was the paper's lead author.

Instead of directly targeting the virus like most conventional antivirals, these drugs work primarily by moderating the body's immune response to the virus and by promoting repair of damaged lung tissue, said Rasmussen.

Working with the team of scientists in the UW Viromics Lab, led by Dr. Michael Katze, UW professor of microbiology, Rasmussen and her colleagues watched how the lung cells responded to the new treatment by tracking their gene expression profiles.

They did this by studying RNA extracted from the infected monkeys' lungs to track changes in what is called the transcriptome. When a cell needs to use a gene, it copies the gene's DNA-encoded instructions into RNA. That RNA transcript is then read to direct the assembly of a protein. By using a "lab on a chip" technology, called a microarray, it is possible to detect and measure RNA transcripts from all the genes in a population of cells. By analyzing the transcriptome, it is then possible to track how cells or a tissue respond to infection, a drug, or some other stimulus. In this case, it allows researchers to study the host response to MERS-CoV in the context of the entire complex biological system, rather than one gene at a time.

Treatment with interferon-alpha 2b and ribavirin appeared to have several interesting effects. The combination increased the transcription of genes that fight viral infections, for example, and reduced transcription of genes that promote inflammation. Of particular interest to Rasmussen and her colleagues, however, was the finding that treatment increased the transcription of genes that assist in regulating a protein called sonic hedgehog.

The sonic hedgehog protein helps moderate the immune response so that it targets the virus more precisely. This honing in reduces collateral damage from broader, less discriminate attack, and helps stimulate repair and growth of lung tissue.

During infection with many severe respiratory viruses, such as influenza, much of the damage is done, not by the virus, but by the body's uncontrolled immune response to the virus, Rasmussen said.

The findings of this new study suggest that, in the case of MERS-CoV infections, interferon-alpha 3b and ribavirin may work primarily by reducing damaging inflammation of the lung and promoting healing by altering the host response, rather than directly targeting the virus.

If that is the case, other drugs that can similarly modulate the body's reaction to viral infections may also prove to be effective against MERS-CoV and other infectious agents, she said.

Reference: Falzarano et al. Interferon-á2b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques. Nature Medicine DOI: 10.1038/nm.3362 (2013).

Leila Gray | EurekAlert!
Further information:
http://www.uw.edu

More articles from Life Sciences:

nachricht Newly designed molecule binds nitrogen
23.02.2018 | Julius-Maximilians-Universität Würzburg

nachricht Atomic Design by Water
23.02.2018 | Max-Planck-Institut für Eisenforschung GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>